-
Signature
-
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. By: Wellington Management Company LLP, as Investment Adviser By: /s/ Jennifer C. Boylan, Authorized Signatory
-
Stock symbol
-
ZBIO
-
Transactions as of
-
Sep 16, 2024
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
9/18/2024, 05:16 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
ZBIO |
Common Stock |
Conversion of derivative security |
|
+181K |
|
|
181K |
Sep 16, 2024 |
Direct |
F1 |
transaction |
ZBIO |
Common Stock |
Conversion of derivative security |
|
+420K |
+232.66% |
|
601K |
Sep 16, 2024 |
Direct |
F1, F2 |
transaction |
ZBIO |
Common Stock |
Conversion of derivative security |
|
+201K |
+33.4% |
|
802K |
Sep 16, 2024 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
ZBIO |
Series A Convertible Preferred Stock |
Conversion of derivative security |
|
-1.57M |
-100% |
|
0 |
Sep 16, 2024 |
Common Stock |
181K |
|
Direct |
F1 |
transaction |
ZBIO |
Series B Convertible Preferred Stock |
Conversion of derivative security |
|
-3.65M |
-100% |
|
0 |
Sep 16, 2024 |
Common Stock |
420K |
|
Direct |
F2 |
transaction |
ZBIO |
Series C Convertible Preferred Stock |
Conversion of derivative security |
|
-1.74M |
-100% |
|
0 |
Sep 16, 2024 |
Common Stock |
201K |
|
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Explanation of Responses: